Image

Diagnosis of Multiple Cancer and Monitoring of Minimal Residual Tumors After Treatment Using Blood and High-Sensitivity Genetic Analysis Techniques

Investigational Study on Blood-Based Monitoring of Multiple Cancers

Recruiting
19 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates multiple cancers. It uses a blood-based method to help diagnose and monitor these cancers after treatment.

The study evaluates a new way to detect tumor DNA in the blood. It looks at how well this method works for finding cancer early and checking for any remaining disease after treatment.

  • Who can participate: Adults aged 19 and older can participate. Participants should be able to donate blood safely and must have been diagnosed with specific cancers or be part of a control group with certain benign conditions.
  • Study details: Participants will have blood tests to check for cancer DNA. Some will also have tissue samples taken during surgery.
Print
Study details
    Lung Neoplasms
    Pancreatic Neoplasms
    Colorectal Neoplasms
    Esophageal Neoplasms
    Ovarian Neoplasms
    Stomach Neoplasms
    Neoplasm Micrometastasis
    Neoplasms

NCT07035587

Yonsei University

31 July 2026

Contact a study center
Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.